SCHEMBL5848025

SCHEMBL5848025

CCOC(=O)CCCCN(c1ccccc1)c1ccc(NC(=O)C2CC(=O)N(c3ccccc3C(C)C)C2)cc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.48
TP53 P04637 2/20 0.46
MAPT P10636 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
POLB P06746 2/20 0.45
ALDH1A1 P00352 6/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
L3MBTL1 Q9Y468 3/20 0.43
NPSR1 Q6W5P4 2/20 0.43
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42
RECQL P46063 1/20 0.41
ATM Q13315 1/20 0.41
KDM4E B2RXH2 1/20 0.41
HPGD P15428 1/20 0.41
MCL1 Q07820 1/20 0.41
HIF1A Q16665 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27617638 0.90 ALOX15 (0.52) ALOX15TP53MAPTMEN1KMT2A
SCHEMBL5841812 0.86 MAPT (0.48) MAPTPOLBALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL5841574 0.85 ALOX15 (0.59) ALOX15TP53MAPTMEN1KMT2A
SCHEMBL5842485 0.85 MAPT (0.47) TP53MAPTMEN1KMT2APOLB
SCHEMBL27617636 0.84 ALOX15 (0.55) ALOX15TP53MAPTMEN1KMT2A
SCHEMBL27617618 0.83 ALOX15 (0.58) ALOX15TP53MAPTMEN1KMT2A
SCHEMBL5841870 0.83 ALOX15 (0.58) ALOX15TP53MAPTMEN1KMT2A
SCHEMBL5842336 0.83 ALOX15 (0.58) ALOX15TP53MAPTMEN1KMT2A
SCHEMBL5843016 0.83 ALDH1A1 (0.46) MAPTKMT2APOLBALDH1A1SMN1; SMN2
SCHEMBL5841918 0.82 ALOX15 (0.57) ALOX15TP53MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100534990-C Pyrrolidone carboxamides ACTELION PHARMACEUTICALS LTD (CH) 2009-09-02 CN disclosed
US-7067549-B2 Pyrrolidone carboxamides ACTELION PHARMACEUTICALS AG (CH) 2006-06-27 US disclosed
US-20050192292-A1 Pyrrolidone carboxamides ACTELION PHARMACEUTICALS AG (CH) 2005-09-01 US disclosed
CN-1610678-A Pyrrolidone carboxamides ACTELION PHARMACEUTICALS LTD (CH) 2005-04-27 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050192292-A1 Pyrrolidone carboxamides NPY1R, NPY5R, NPY2R ALOX15 902/4885TP53 4187/4885MAPT 4395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.